RNA Operating Cash Flow (Statement)
Atrium Therapeutics Inc · Operating Cash Flow (Statement)
RNA Operating Cash Flow (Statement)
Latest reported-$3.93Mperiod ending
RNA Quarterly Cash from Operations (-$19.25M → -$3.93M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
RNA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -3,926,000 | |
| -31,143,000 | |
| -19,252,000 |